Japan has launched clinical trials for a synthetic, universally compatible blood substitute, marking a potential breakthrough ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

A Senate committee rejected Trump's proposed 40% cut to NIH funding. Philadelphia's medical research community says it means ...

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Owen Witte, MD, is recognized for multiple seminal contributions over the past 50 years impacting our understanding of human leukemias, immune disorders, and epithelial cancers, which have defined new ...

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.

Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025: Cambridge, Massachusetts Friday, August 1, 2025, 18 ...

Elon Musk 's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical ...

Neuralink, Elon Musk's brain implant company, is expanding its clinical trials to the UK after its US success. The trials aim ...

Elon Musk's Neuralink is set to conduct a groundbreaking clinical study in Great Britain to test brain chips that allow patients with severe paralysis to control digital tools with their thoughts.